SREA EBITDA
$5.84BTTM · USD
Period ending:
SREA FY EBITDAUSD
$6.87B-$97.00M
2005-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.
SREA ebitda history
Earnings before interest, taxes, depreciation, and amortization. The available annual fiscal periods series contains 21 observations from Dec 31, 2005 to Dec 31, 2025.
| Period ending | EBITDA (USD) |
|---|---|
| 6,868,000,000 | |
| 5,298,000,000 | |
| 5,837,000,000 | |
| 4,517,000,000 | |
| 4,635,000,000 | |
| 4,396,000,000 | |
| 4,377,000,000 | |
| 3,091,000,000 | |
| 3,696,000,000 | |
| 2,938,000,000 | |
| 3,170,000,000 | |
| 2,938,000,000 | |
| 2,997,000,000 | |
| 2,523,000,000 | |
| 1,357,000,000 | |
| 739,000,000 | |
| 1,119,000,000 | |
| 1,113,000,000 | |
| 1,099,000,000 | |
| -97,000,000 | |
| 929,000,000 |
Compare ebitda
Other companies in —. Each page shows its own reporting periods and currency.
- Taiwan Semiconductor Manufacturing Company Ltd. (TSM) ebitda
- HSBC Holdings, plc. Common Stock (HSBC) ebitda
- Shell PLC American Depositary Shares (each representing two (2) Ordinary Shares) (SHEL) ebitda
- Novartis AG Common Stock (NVS) ebitda
- Royal Bank Of Canada Common Stock (RY) ebitda
- Alibaba Group Holding Limited American Depositary Shares each representing eight Ordinary share (BABA) ebitda
- SAP SE ADS (SAP) ebitda
- AstraZeneca PLC Ordinary Shares (AZN) ebitda
All SREA financial metrics · SREA stock overview · How to interpret financial metrics
